The majority of embryos created are unable to survive the first trimester of pregnancy due to chromosomal abnormalities or genetic disease. In answer to this problem, our fertility network and IVF experts in Albany, Rochester, and Syracuse are proud to offer genetic screening testing!

It’s one of the most exciting and effective ways of improving IVF success rates and ensure you give birth to a healthy baby.

IVF GENETIC SCREENING 101

Once embryos are created through in Vitro fertilization (IVF), we offer two different types of genetic testing that can look for chromosomal abnormalities or specific diseases within the embryos prior to implantation. PGT-A (formerly PGS) and PGT-M (formerly PGD) greatly reduce the chance of miscarriage and genetic disease in your embryos.

Through these tests, our team of embryologists assess the genetic makeup of each embryo created via IVF to identify and eliminate abnormalities and genetic disorders.

OUR IVF GENETIC TEST PROGRAM

Our IVF Genetic Testing Program provides 35 years of experience through the hands of personalized, local care. Boston IVF’s history of research and experience allows our physicians to help women and men successfully solve the most complex fertility cases.

PGT-A

• PGT-A specifically identifies chromosomal abnormalities in your embryos prior to implantation via IVF. Chromosomal abnormalities are the cause of most miscarriages, so PGT-A testing is an important precautionary measure to ensure a healthy pregnancy.
• The chance of chromosomal errors, called aneuploidy, greatly increases with a woman’s age. By age 40, 58% of a woman’s chromosomes are chromosomally abnormal.
• This is why older women have such a high risk of miscarriage or birth with chromosomal disorder such as Down Syndrome.
• PGT-A is an extremely accurate tool to address the high risk of aneuploidy that accompanies aging for women.

WHO USES PGT-A?

• Women age 35+
• Women who have experienced recurrent miscarriage
• Women with previous failed IVF cycles

WHY USE PGT-A?

• Increases IVF success rate
• Increases chance of embryo implantation
• Increases chance of genetically healthy baby
• Reduces risk of failed IVF cycles
• Reduces risk of miscarriage

PGT-M

PGT-M is a different test that PGT-A.

PGT-M assesses your embryos for specific gene diseases prior to implantation via IVF. Our embryologists remove one single cell from each created embryo to effectively identify genetic abnormalities.

If you or your partner have a family history of inherited genetic disease, PGT-M is your best tool to stop the cycle and prevent passing on to your children.

WHO USES PGT-M?

• Individuals and couples with a family history of inherited genetic disease
• Individuals and couples who are carriers of a chromosomal mutation

WHY USE PGT-M?

• Analyzes embryos for 400+ hereditary diseases prior to IVF
• Reduces your risk of passing on genetic abnormalities to your child
• Increase your chance of a healthy birth

SINGLE GENE DISORDERS ELIMINATED VIA PGT-M

• Autosomal dominant polycystic kidney disease
• Becker’s muscular dystrophy
• Beta thalassemia
• Cystic fibrosis
• Charcot-Marie-Tooth disease type 1A
• Duchenne muscular dystrophy
• Familial amyloid polyneuropathy
• Fragile X syndrome
• Hemophilia A (F8)
• Hemophilia B (F9)
• Huntington’s disease
• Multiple endocrine neoplasia, type 2A
• Myotonic dystrophy (Steinert’s disease)
• RhD incompatibility
• Spinal muscular atrophy

YOUR FIRST STEP

Whether you would like to schedule a consultation with a fertility doctor or just need some basic advice, don’t hesitate to call or email us!